Article Details

Infinity Pharmaceuticals (NASDAQ:INFI) Earns Buy Rating from Analysts at B. Riley

Retrieved on: 2019-12-12 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Infinity Pharmaceuticals (NASDAQ:INFI) Earns Buy Rating from Analysts at B. Riley. View article details on HISWAI:

Excerpt

<div><b>Acadian Asset Management</b> LLC grew its stake in Infinity Pharmaceuticals by 10.9% in the second quarter. <b>Acadian Asset Management</b> LLC now ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up